PPARG and memory impairment: The current study aimed to evaluate improving effects of pioglitazone as an agonist PPARγ, on the concentration of brain-derived neurotrophic factor (BDNF) and cytokines in the hippocampus as well as hippocampal tissue oxidative damage criteria in a rat model of lipopolysaccharide (LPS) induced memory impairment.